Concepedia

Karl Mulligan

KM

8

Publications

539

Citations

8

H-Index

2000

Active since

Affiliations

Queen's University Belfast(Current)

University of Ulster

Belfast City Hospital

Almac (United Kingdom)

Karl Mulligan is an author at Queen's University Belfast specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2000–2021

8

Publications

8

Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue

Richard D. Kennedy, Max Bylesjö, Peter Kerr et al. · Journal of Clinical Oncology · 2011 · 187 citations

Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells

A Hill, Suzanne McFarlane, Karl Mulligan et al. · Oncogene · 2006 · 123 citations

, , +10

BRCA1 and c-Myc Associate to Transcriptionally Repress Psoriasin, a DNA Damage–Inducible Gene

Richard D. Kennedy, Julia J. Gorski, Jennifer E. Quinn et al. · Cancer Research · 2005 · 89 citations · Full text

TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.

Zenobia D’Costa, Catherine Higgins, Chee Wee Ong et al. · Oncotarget · 2014 · 43 citations · Full text

Epidermal growth factor up-regulates CD44-dependent astrocytoma invasionin vitro

Monica Monaghan, Karl Mulligan, H. B. Gillespie et al. · The Journal of Pathology · 2000 · 37 citations

, , +13

Rows per page

1–5 of 8